S

Synthaverse SA
WSE:SVE

Watchlist Manager
Synthaverse SA
WSE:SVE
Watchlist
Price: 4.34 PLN -0.57% Market Closed
Market Cap: 307.1m PLN
Have any thoughts about
Synthaverse SA?
Write Note

Intrinsic Value

The intrinsic value of one SVE stock under the Base Case scenario is 6.46 PLN. Compared to the current market price of 4.34 PLN, Synthaverse SA is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SVE Intrinsic Value
6.46 PLN
Undervaluation 33%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Synthaverse SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SVE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SVE?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Synthaverse SA

Provide an overview of the primary business activities
of Synthaverse SA.

What unique competitive advantages
does Synthaverse SA hold over its rivals?

What risks and challenges
does Synthaverse SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Synthaverse SA.

Provide P/S
for Synthaverse SA.

Provide P/E
for Synthaverse SA.

Provide P/OCF
for Synthaverse SA.

Provide P/FCFE
for Synthaverse SA.

Provide P/B
for Synthaverse SA.

Provide EV/S
for Synthaverse SA.

Provide EV/GP
for Synthaverse SA.

Provide EV/EBITDA
for Synthaverse SA.

Provide EV/EBIT
for Synthaverse SA.

Provide EV/OCF
for Synthaverse SA.

Provide EV/FCFF
for Synthaverse SA.

Provide EV/IC
for Synthaverse SA.

Show me price targets
for Synthaverse SA made by professional analysts.

What are the Revenue projections
for Synthaverse SA?

How accurate were the past Revenue estimates
for Synthaverse SA?

What are the Net Income projections
for Synthaverse SA?

How accurate were the past Net Income estimates
for Synthaverse SA?

What are the EPS projections
for Synthaverse SA?

How accurate were the past EPS estimates
for Synthaverse SA?

What are the EBIT projections
for Synthaverse SA?

How accurate were the past EBIT estimates
for Synthaverse SA?

Compare the revenue forecasts
for Synthaverse SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Synthaverse SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Synthaverse SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Synthaverse SA compared to its peers.

Compare the P/E ratios
of Synthaverse SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Synthaverse SA with its peers.

Analyze the financial leverage
of Synthaverse SA compared to its main competitors.

Show all profitability ratios
for Synthaverse SA.

Provide ROE
for Synthaverse SA.

Provide ROA
for Synthaverse SA.

Provide ROIC
for Synthaverse SA.

Provide ROCE
for Synthaverse SA.

Provide Gross Margin
for Synthaverse SA.

Provide Operating Margin
for Synthaverse SA.

Provide Net Margin
for Synthaverse SA.

Provide FCF Margin
for Synthaverse SA.

Show all solvency ratios
for Synthaverse SA.

Provide D/E Ratio
for Synthaverse SA.

Provide D/A Ratio
for Synthaverse SA.

Provide Interest Coverage Ratio
for Synthaverse SA.

Provide Altman Z-Score Ratio
for Synthaverse SA.

Provide Quick Ratio
for Synthaverse SA.

Provide Current Ratio
for Synthaverse SA.

Provide Cash Ratio
for Synthaverse SA.

What is the historical Revenue growth
over the last 5 years for Synthaverse SA?

What is the historical Net Income growth
over the last 5 years for Synthaverse SA?

What is the current Free Cash Flow
of Synthaverse SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Synthaverse SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Synthaverse SA

Current Assets 51.1m
Cash & Short-Term Investments 11.2m
Receivables 24.1m
Other Current Assets 15.8m
Non-Current Assets 240.6m
Long-Term Investments 7m
PP&E 229m
Intangibles 585k
Other Non-Current Assets 4.1m
Current Liabilities 42.1m
Accounts Payable 24.2m
Accrued Liabilities 4.7m
Other Current Liabilities 13.1m
Non-Current Liabilities 137.4m
Long-Term Debt 63m
Other Non-Current Liabilities 74.4m
Efficiency

Earnings Waterfall
Synthaverse SA

Revenue
60.5m PLN
Cost of Revenue
-24m PLN
Gross Profit
36.5m PLN
Operating Expenses
-28.4m PLN
Operating Income
8.1m PLN
Other Expenses
-4.5m PLN
Net Income
3.6m PLN

Free Cash Flow Analysis
Synthaverse SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SVE Profitability Score
Profitability Due Diligence

Synthaverse SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Operating Income
Positive 1-Year Revenue Growth
48/100
Profitability
Score

Synthaverse SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

SVE Solvency Score
Solvency Due Diligence

Synthaverse SA's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Short-Term Solvency
52/100
Solvency
Score

Synthaverse SA's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SVE Price Targets Summary
Synthaverse SA

Wall Street analysts forecast SVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SVE is 6.63 PLN with a low forecast of 6.57 PLN and a high forecast of 6.83 PLN.

Lowest
Price Target
6.57 PLN
51% Upside
Average
Price Target
6.63 PLN
53% Upside
Highest
Price Target
6.83 PLN
57% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SVE?

Click here to dive deeper.

Dividends

Synthaverse SA
does not pay dividends
Shareholder Yield

Current shareholder yield for SVE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Synthaverse SA

Country

Poland

Industry

Biotechnology

Market Cap

306.1m PLN

Dividend Yield

0%

Description

Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. The company is headquartered in Lublin, Woj. Lubelskie and currently employs 234 full-time employees. The company went IPO on 2011-07-29. The firm focuses on the production of drugs in the field of immunotherapy. Synthaverse SA offers its services in the field such as: oncological immunotherapy, Immunotherapy in Serological Conflict, Passive immunotherapy in hepatitis B, Active anti-tuberculosis immunotherapy, Gynecology and Proctology, Probiotics, Laboratory reagents. The firm offers injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, suppository forms of drugs. The firm supplies its products to 50 countries around the world.

Contact

WOJ. LUBELSKIE
Lublin
Ul. Uniwersytecka 10
+48815338221
synthaverse.pl

IPO

2011-07-29

Employees

234

Officers

Secretary of Supervisory Board & Member of Supervisory Board
Mr. Waldemar Sierocki
President of the Management Board & CEO
Mr. Mieczyslaw Starkowicz
Chief Financial Officer
Radoslaw Wroblewski
Chief Organizational & Legal Officer and Member of the Management Board
Mr. Jakub Winkler
Chief Accountant
Ms. Katarzyna Krukowoska

See Also

Discover More
What is the Intrinsic Value of one SVE stock?

The intrinsic value of one SVE stock under the Base Case scenario is 6.46 PLN.

Is SVE stock undervalued or overvalued?

Compared to the current market price of 4.34 PLN, Synthaverse SA is Undervalued by 33%.

Back to Top